On 27 November, NIHR Moorfields BRC hosted an event for patients participating in the KERALINK trial, along with their parents, other keratoconus patients, relatives, friends and healthcare professionals.
The aim of the event was to share the outcomes of the keratoconus KERALINK study, learn about current research in keratoconus, and for the audience to input into future research priorities.
Keratoconus affects the cornea, which is the clear dome-shaped window at the front of the eye. In keratoconus, the cornea becomes weaker and thinner at its centre. This can make vision blurry and distorted. Keratoconus usually develops in a person's teens or 20s, and can worsen over time.